Research records indexed for LL-37
This page carries 12 of the 2,666 records that the literature query returned for LL-37, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 2,654 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is LL-37.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator pmid:26556394 | 2016 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Humans" with no interventional publication type. subject headings: Cell Membrane; Antimicrobial Cationic Peptides; Wound Healing; Protein Structure, Secondary; Structure-Activity Relationship. |
| Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization pmid:26053625 | 2015 | Research Support, Non-U.S. Gov't, research-article | rodent | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Mice, Inbred C57bl". subject headings: Gastrointestinal Tract; HT29 Cells; Mice, Inbred C57BL; Bacteroides; Candida Albicans. |
| Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease pmid:24185823 | 2013 | research-article, Review | rodent | Not stated | Indexed as research-article, review. study model from MeSH "Mice". subject headings: Arthritis, Rheumatoid; Dermatitis, Atopic; Lupus Erythematosus, Systemic; Psoriasis; Autoimmune Diseases. |
| A comprehensive summary of LL-37, the factotum human cathelicidin peptide pmid:23246832 | 2012 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Animals" with no rodent species heading. subject headings: Vitamin D; Antimicrobial Cationic Peptides; Monitoring, Immunologic; Wound Healing; Signal Transduction. |
| Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 pmid:22031815 | 2011 | Research Support, Non-U.S. Gov't, research-article | rodent | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Mice, Inbred Balb C". subject headings: Lung; Cell Line; Mice, Inbred BALB C; Dogs; Orthomyxoviridae Infections. |
| Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37 pmid:21464330 | 2011 | Research Support, American Recovery and Reinvestment Act, research-article | other | Not stated | Indexed as research support, american recovery and reinvestment act, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Pseudomonas Aeruginosa; Escherichia Coli; Antimicrobial Cationic Peptides; Cathelicidins. |
| Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization pmid:22069323 | 2011 | research-article, Research Support, N.I.H., Extramural | other | Not stated | Indexed as research-article, research support, n.i.h., extramural. study model from MeSH "Humans" with no interventional publication type. subject headings: Cell Line; Mast Cells; Calcium; Antimicrobial Cationic Peptides; Receptors, G-Protein-Coupled. |
| Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37 pmid:20945332 | 2010 | research-article, Research Support, N.I.H., Extramural | rodent | Not stated | Indexed as research-article, research support, n.i.h., extramural. study model from MeSH "Mice, Inbred C57bl". subject headings: Mesenchymal Stem Cells; Bronchoalveolar Lavage Fluid; Mice, Inbred C57BL; Escherichia Coli; Pneumonia. |
| Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells pmid:20190140 | 2010 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Cells, Cultured; Mast Cells; Skin; Inflammation; Beta-Defensins. |
| The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells pmid:19234121 | 2009 | Research Support, Non-U.S. Gov't, research-article | rodent | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Mice". subject headings: Cell Line, Tumor; Stromal Cells; Multipotent Stem Cells; Mesoderm; Ovarian Neoplasms. |
| The roles of cathelicidin LL-37 in immune defences and novel clinical applications pmid:19068548 | 2009 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Humans" with no interventional publication type. subject headings: Antimicrobial Cationic Peptides; Drug Design; Cathelicidins; Immunity, Innate; Transcriptional Activation. |
| Human host defense peptide LL-37 prevents bacterial biofilm formation pmid:18591225 | 2008 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Biofilms; Pseudomonas Aeruginosa; Polymyxin B; Antimicrobial Cationic Peptides; Anti-Bacterial Agents. |
Where this page sits
Compound page: LL-37. Class: Tissue repair peptides.
Retrieved 2026-10-12.
Sources
- PubChem Compound Summary for CID 16198951, LL-37. PubChem, National Library of Medicine (2026). pubchem:16198951
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ll-37
- LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochimica et biophysica acta (2006). pmid:16716248
- Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood (2001). pmid:11389039
- Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrobial agents and chemotherapy (1998). pmid:9736536
- Human host defense peptide LL-37 prevents bacterial biofilm formation. Infection and immunity (2008). pmid:18591225
- The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. The Journal of biological chemistry (1997). pmid:9182550
- The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America (1998). pmid:9689116
- The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000). pmid:11049988
- LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. The Journal of experimental medicine (2000). pmid:11015447
- The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Journal of immunology (Baltimore, Md. : 1950) (2002). pmid:12244186
- An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. The Journal of clinical investigation (2003). pmid:12782669
- Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem cells (Dayton, Ohio) (2010). pmid:20945332
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.